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Abstract
Background: While modern electronic data collection methods (e.g., computer touch-screen or web-based) hold
much promise, most current studies continue to make use of more traditional data collection techniques, including
paper-and-pencil administration and telephone interviews. The present randomized trial investigated the
measurement properties of the EORTC QLQ-C30 under three different modes of administration (MOA’s).
Methods: A heterogeneous sample of 314 cancer patients undergoing treatment at a specialized treatment center
in Amsterdam were randomized to one of three MOA’s for the QLQ-C30: paper-and-pencil at home via the mail,
telephone interview, and paper-and-pencil at the hospital clinic. Group differences in internal consistency
reliabilities (Cronbach’s alpha coefficient) for the scale scores were compared. Differences in mean scale scores
were also compared by means of ANOVA, with adjustment for potential confounders.
Results: Only one statistically significant, yet minor, difference in Cronbach’s alpha between the MOA groups was
observed for the Role Functioning scale (all 3 alphas >0.80). Significant differences in group means -after
adjustment- were found for the Emotional Functioning (EF) scale. Patients completing the written questionnaire at
home had significantly lower levels of EF as compared to those interviewed via the telephone; EF scores of those
completing the questionnaire at the clinic fell in-between those of the other two groups. These differences,
however, were small in magnitude.
Conclusions: MOA had little effect on the reliability or the mean scores of the EORTC QLQ-C30, with the possible
exception of the EF scale.
Background
Health-related quality of life (HRQoL) questionnaires
can be administered using a variety of methods, includ-
ing face-to-face or telephone interviews, pencil and
paper, computer touch-screen, or web-based. However,
not all researchers may have equal access to all modes
of administration (MOA). For example, despite the
attractiveness of high-tech electronic methods, none of
the 107 abstracts cited in PubMed for 2007 concerning
the EORTC QLC-C30 HRQoL questionnaire reported
having used a computer for data collection.
In addition, various MOA may not be equally practical
for all respondents. For example, lack of language or
computer skills may preclude the use of written ques-
tionnaires, whether pencil and paper or computer-based.
It may also be sometimes necessary to combine multiple
modes of administration in the same study, for example
when conducting longitudinal research or combining
data from various sources.
For these reasons, it is important to consider whether
the measurement characteristics of various MOA’sa r e
equivalent, because, if this is not the case, then it would
be difficult to compare outcomes across MOA’sw i t h i n
or between studies. Many studies of varying designs,
sizes, populations, and instruments have considered this
issue, with generally similar results [1-9]. Namely, the
effects of MOA on questionnaire measurement charac-
teristics are generally not large. However, only two stu-
dies have investigated the effect of MOA on the EORTC
QLQ-C30, one of the most widely used HRQoL
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observational study, Cheung et al. [14] investigated the
effect of two MOA’s, in-clinic interview with in-clinic
paper-and-pencil, on the measurement properties on 4
multi-item scales of the QLQ-C30. Velikova et al. [15]
u s e da l l1 5s c a l e so ft h eQ L Q - C 3 0i nar a n d o m i z e d ,
cross-over study of 149 patients, comparing in-clinic
touch-screen with in-clinic paper & pencil administra-
tion. Despite their differences and limitations, these two
studies each found several small, yet statistically signifi-
cant, differences in scale mean scores as a function of
MOA’s (approximately 3-7 points on a 100 point scale).
Both studies flagged the Emotional Functioning Scale as
being potentially problematical.
The purpose of the current study was to investigate, in
a controlled, randomized setting, the measurement char-
acteristics of the EORTC QLQ C-30 under a variety of
different, conventional MOA’s.
Methods
Study Sample
The study sample employed in the current analysis was
composed of participants in a study conducted by te
Velde and colleagues that evaluated various instruments
for HRQoL assessment in oncology [15,16].
Patients
The patient sample was composed of individuals with a
variety of cancer diagnoses (primarily breast, colorectal,
and lung) with various disease stages (local, loco-regio-
nal, or metastasized) who attended the Netherlands
Cancer Institute/Antoni van Leeuwenhoek Hospital for
treatment. The data used in the current analysis were
collected approximately 4 months after start of radio- or
chemotherapy, during the third measurement wave (T3)
in a longitudinal study.
Exclusion criteria includedal i f ee x p e c t a n c yo fl e s s
than 4 months, too ill to participate, participation in a
concurrent HRQoL study, less than 18 years of age, and
a lack of basic proficiency inD u t c h .N or e s t r i c t i o n s
were made with regard to age or performance status.
Eligible patients received a full, verbal and written expla-
nation of the purpose and procedures of the study. The
study was approved by the local ethics committee, and
written informed consent was obtained from all partici-
pating patients.
Patient Characteristics
A number of variables, which were possibly relevant for
the quality of patient ratings of HRQoL, were measured
for the purpose of describing the sample of patients, as
well as for assessing the quality of the randomization
into three groups. Characteristics of the patients
included: indicators of health (i.e., the Karnofsky Perfor-
mance Status scale [17]), treatment and disease
characteristics, comorbidity, sociodemographic data, and
the EORTC QLQ-C30 questionnaire data collected dur-
ing the previous (in-clinic) measurement wave at T2.
Procedure
To assess the impact of different MOA’so nt h em e a -
surement performance of the EORTC QLQ-C30,
patients were randomly assigned (with equal probabil-
ities), during the first measurement wave of the study at
T1, to one of three groups during the third measure-
ment wave at T3: in-clinic written self-administration;
telephone-based interviewer-administration, or mailed
written self-administration.
Health-related quality of life (HRQoL) assessment
HRQoL was assessed with the European Organization
for Research and Treatment of Cancer (EORTC) Quality
of Life Questionnaire (QLQ-C30 (version 2.0)) [10-13].
It includes 5 functional scales (physical, role, cognitive,
emotional, and social), 3 symptom scales (fatigue, nausea
and vomiting, and pain), 6 single items (dyspnea, insom-
nia, anorexia, constipation, diarrhea, and financial
impact), and 1 global quality of life scale. The question-
naire employs a one-week time frame and a mix of
dichotomous response categories ("yes/no”), 4-point
Likert-type response scales (ranging from “not at all” to
“very much”), and 7-point response scales (numbered
visual analogue scales). The scoring procedures recom-
mended by the EORTC [13] were used. All scale and
single item scores of the QLQ-C30 were linearly trans-
formed to a 0 to 100 scale. For the functioning scales,
higher scores represent a better level of functioning; for
the symptom measures, a higher score corresponds to a
higher level of symptomology.
The QLQ-C30 has been shown to be reliable and valid
in a range of patient populations and treatment settings.
Across a number of studies, internal consistency esti-
mates (Cronbach’s coefficient a) of the multi-item scales
exceeded or approached 0.70 [12]. Test-retest reliability
coefficients have been found to range between 0.80 and
0.90 for most multi-item scales and single items [18].
T e s t so fv a l i d i t yh a v es h o w nt h eQ L Q - C 3 0t ob e
responsive to meaningful between-group differences
(e.g., local vs. metastatic disease, active treatment vs. fol-
low-up) and changes in clinical status over time [10,12].
Statistical Methods
Mean scores and standard deviations for the QLQ-C30
scales, as well as for the characteristics of the patients
were calculated. The internal consistency of the multi-
item scales of the QLQ-C30 was assessed by Cronbach’s
coefficient alpha [19,20].
Differences in scale/item means were tested by means
of analysis of co-variance (ANCOVA), which allowed
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magnitude of any observed difference between MOA’s,
mean difference scores between groups were then stan-
dardized by dividing them by the pooled standard devia-
tion, in order to estimate an effect size [21]. Following
Cohen [21], effect sizes of 0.20, 0.50, and 0.80 were con-
sidered small, medium, and large, respectively. Osoba et
al. [22] determined that a difference of 10 or fewer
points on the (re-scaled) QLQ-C30 scales could be
viewed as being “small”.
Levene’s test for the equality of variances between
groups was also calculated. Finally, multiple analysis of
(co-)variance provided a multivariate test of differences
between groups, with adjustment for possible
confounders. For all tests, the type I error (alpha) signif-
icance level was set at 0.05.
Results
Sample accrual (Figure 1)
During the study period, 614 patients who met the elig-
ibility criteria were invited to participate in the study, of
whom 483 (79%) accepted at T1. Reasons for declining
study participation included: (a) the study was perceived
as too emotionally burdensome (n = 54); (b) perceived
lack of time (n = 22); (c) lack of interest (n = 18); or (d)
being too ill (n = 10). The remaining 29 patients had a
variety of other reasons. Patients declining participation
were, on average, older (mean age 65 years vs. 57 years),
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Figure 1 Results of Patient accrual and randomization.
Gundy and Aaronson Health and Quality of Life Outcomes 2010, 8:35
http://www.hqlo.com/content/8/1/35
Page 3 of 7were less frequently married (59% vs. 76%), and more
often had compulsory education only (91% vs. 82%),
than those who participated.
Of the 483 patients initially enrolled in the study, and
randomized at the first assessment point T1, 375 (78%)
remained available for the actual measurement at T3,
which was used for the present analysis. The primary
reasons for patient attrition were severe illness (n =3 6 )
or death (n = 35). Patients lost to follow-up were more
likely to have metastatic disease, and their KPS was 10
to 30 points lower than patients who continued partici-
pation. The average time between Tl and T3 was
128 days.
However, after randomization, 11 patients declined to
participate in the MOA condition to which they were
assigned, and 50 patients randomized to the in-clinic
condition did not attend the hospital for a follow-up
visit that coincided with this -third- assessment point.
These patients were also excluded from further analysis.
Statistical Power
We determined that the present sample size would be
able to detect a “medium” effect size for differences in
means (d = 0.50) between two groups with a power
exceeding 90%, (assuming a two-sided test with a signifi-
cance of 5%) [21].
Sample characteristics (Tables 1 and 2)
Characteristics of the patients in each of the three MOA
groups are presented in Table 1. Pre-test HRQoL mea-
surements, taken at T2, are presented in Table 2. Of
those patients remaining in the study at T3, very few
data were missing, not exceeding 3% for any of the
QLQ-C30 scales for any of the three conditions (data
not shown). Mainly due to the loss of the 50 patients
randomized to the in-clinic condition, there was an
imbalance in the number of patients per group, and in
the distribution of stage of disease, type of treatment,
and several previous QLQ-C30 scale scores between the
three groups. These 50 dropout-patients differed from
the patients remaining in the in-clinic condition primar-
ily in terms of type of treatment (p < 0.05, after adjust-
ment for other predictors).
Internal Consistency of the QoL proxy scales (Table 3)
Cronbach’sa l p h a ’s for the multi-item scales for each
group were generally adequate (i.e., > 0.70) in the large
majority of cases. The consistent exception was the Cog-
nitive Functioning scale; something that has been
observed in many other studies. There was a significant
difference between the in-clinic paper-and-pencil and
the telephone conditions for the Role Functioning (RF)
scale, even though this scale performed rather well
(alpha > = 0.8) for all three conditions.
Mean QLQ-C30 scale score differences (Table 4)
The adjusted means and standard errors of the three
MOA groups for each of the 15 QLQ-C30 scales are
presented in Table 4. After adjustment for the possible
confounders shown in Table 1 and 2, significant group
differences were found only for Emotional Functioning
(EF). The telephone condition had the highest EF, and
the paper-and-pencil at-home condition the lowest. The
Table 1 Patient sample characteristics (n = 314) for 3
MOA groups
Individual
Characteristics
Paper & pencil
at home
(n = 132)
Telephone
(n = 121)
Paper &
pencil
in-clinic
(n = 61)
Means (s.d.) Means (s.d.) Means (s.d.) Sig.
Age 56.6(12.9) 57.0(12.0) 54.1(11.5) .30
KPS 77.4(14.4) 78.1(13.7) 78.0(15.0) .93
N(%) N(%) N(%)
Sex (%)
Male 48(36%) 47(39%) 16(27%) .23
Marital Status
Single 11(8%) 9(8%) 6(10%) .92
Married 99(75%) 97(81%) 44(73%)
Divorced 10(8%) 7(6%) 5(8%)
Widowed 12(9%) 7(6%) 5(8%)
Education
<10 years 70(53%) 69(58%) 32(53%) .21
10-15 years 39(30%) 35(29%) 12(20%)
>15 years 23(17%) 16(13%) 16(27%)
Employed
Yes 50(38%) 41(35%) 19(32%) .70
Stage of Disease*
Local/regional 86(66%) 73(61%) 28(47%) .04
Treatment**
Chemotherapy 56(42%) 50(41%) 44(73%) <.00
Radiotherapy 70(53%) 67(55%) 15(25%)
RT+CT/other 6(5%) 4(3%) 1(2%)
Comorbidity
Yes 74% 74% 69% .76
Primary Site
Breast 48(36%) 49(41%) 32(53%) .11
Colorectal 38(29%) 31(26%) 10(17%)
Lung 36(27%) 29(24%) 9(15%)
Other 10(8%) 12(10%) 9(15%)
*p < 0.05 **p < 0.01
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tions was approximately 6 points, the adjusted mean dif-
ference being only 5.4 points. The pair-wise Cohen’sd ’s
for the “telephone vs. paper & pencil at home”,t h e
“paper & pencil at home vs. pencil & paper in-clinic”,
and the “telephone vs. paper & pencil in-clinic” condi-
tions were 0.31, 0.14, 0.19, respectively. These results
qualify the MOA effect for the EF scale as being “small”.
An additional analysis was conducted, adding a fourth
group of patients to the above analyses of differences
between means. This fourth group consisted of the
patients who were not available for the in-clinic paper &
pencil condition because they did not return to the
clinic at T3. These patients were invited to complete the
questionnaire in the same manner as the “paper & pen-
cil at home” condition. Results indicated that patients in
this fourth group had significantly poorer scores for the
EF and SL scales as compared to the” telephone” condi-
tion, and did not differ from the original paper & pencil
conditions (data not shown).
Miscellaneous statistical tests
A Levene test for difference in variances between the
groups was significant for Pain, Appetite loss, and
Financial Difficulties (p < 0.05). A multivariate analysis
of variance (Pillai’s trace/Wilk’s lambda, with adjustment
for confounders) found no significant difference (p =
0.40) between the three groups. (Data not presented.)
Discussion
In this study we investigated several measurement prop-
erties of the EORTC QLQ-C30 questionnaire under var-
ious MOA’s. Despite the widespread use of the EORTC
QLQ-C30, only two studies had previously investigated
this matter. One large observational study considered 4
of the QLQ-C30 multi-item scales [14], while the other
study used a randomized, cross-over design, but with a
much smaller sample size, and with only two (in-clinic)
conditions [15].
The present study of a heterogeneous population of
375 cancer patients considered three conditions (at-
home as well as in-clinic) in a randomized, between-
subjects trial.
Remarkably, all three of these studies flag the Emo-
tional Functioning (EF) scale as yielding a small, yet sta-
tistically significant difference as a function of MOA,
Table 2 Patient sample characteristics (n = 314) for 3 MOA groups at Pretest (T2)
QLQ-C30
at pre-test (T2)
Paper & pencil at home
(n = 132)
Telephone
(n = 121)
Paper & pencil in-clinic
(n = 61)
Mean (s.d.) %
floor/ceiling
Mean (s.d.) %
floor/ceiling
Mean (s.d.) %
floor/ceiling
Sig.
Physical function 62.0(28.9) 2%/23% 69.9(23.0) 2%/26% 66.8(24.2) 2%/23% .052
Role function 59.2(31.3) 4%/27% 67.9(28.3) 5%/36% 66.9(28.6) 12%/35% .050
Cognitive function* 80.0(18.4) 0%/43% 82.5(18.9) 1%/50% 87.2(14.4) 0%/39% .038
Emotional function 74.4(21.0) 1%/20% 77.7(19.6) 1%/36% 78.6(18.7) 0%/26% .294
Social function 76.5(27.6) 2%/52% 82.8(20.5) 1%/60% 81.7(22.7) 2%/51% .103
GlobalHealth/QoL 61.5(22.0) 1%/6% 67.2(19.5) 1%/12% 66.1(19.6) 0%/8% .078
Fatigue 45.6(26.0) 13%/3% 38.2(23.5) 21%/3% 40.1(26.9) 15%/3% .060
Nausea/vomitig 14.1(21.3) 69%/1% 10.4(19.0) 76%/1% 13.4(18.5) 62%/2% .321
Pain** 30.5(29.9) 30%/3% 24.7(26.2) 45%/4% 14.8(20.4) 46%/0% .001
Dyspnea 20.1(27.9) 55%/4% 18.1(24.0) 55%/0% 18.0(24.0) 51%/2% .785
Insomnia 30.0(33.8) 52%/8% 29.4(31.8) 63%/2% 21.9(28.5) 57%/3% .226
Anorexia 24.2(29.8) 72%/2% 19.1(29.3) 72%/5% 22.2(29.9) 66%/2% .392
Constipation 11.8(23.8) 83%/2% 7.8(19.2) 87%/1% 12.0(21.1) 82%/0% .268
Diarrhea 10.8(21.7) 85%/1% 11.7(22.7) 85%/0% 4.4(13.0) 87%/0% .074
Financial 8.2(19.0) 82%/1% 5.6(13.9) 89%/2% 3.3(11.7) 90%/0% .117
*p < 0.05 **p < 0.01
Table 3 Cronbach’s alpha’s for multi-item Scales for
three MOA groups
EORTC QLQ-C30
Multi-item Scales
Paper & pencil
at home
(N = 132)
Telephone
(N = 121)
Paper & pencil
in-clinic
(N = 61)
Physical function 0.69 0.71 0.69
Role function*
& 0.87 0.80 0.93
Cognitive function 0.57 0.64 0.57
Emotional function 0.86 0.86 0.84
Social function 0.78 0.64 0.81
Global health/QoL 0.84 0.84 0.89
Fatigue 0.87 0.87 0.88
Nausea/vomiting 0.73 0.75 0.64
Pain 0.86 0.87 0.79
*p < 0.05
**p < 0.01
& The significant difference in this comparison is between the telephone
versus the in-clinic Paper & Pencil condition
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levels of emotional functioning. The present study also
found a small, yet significant difference in Cronbach’s
alpha for the Role Functioning scale; however, the RF
scale performed quite adequately for all three conditions.
We suspect that the slightly lower EF scale scores in
paper-and-pencil conditions may be related to the
“demand characteristics” associated with different
MOA’s. Specifically, patients, who are encouraged to
react quickly and/or who are required to interact with
an interviewer, may be stimulated to present more
socially desirable responses than those patients allowed
to reflect on their level of emotional functioning and
whose responses to the questions are not the subject of
direct observation. For example, patients are asked in
the QLQ-C30 whether they are depressed, which is not
a directly observable state, and whose admission might
be felt as being potentially stigmatizing.
Many studies of varying designs, sizes, populations,
and instruments have considered the issue of measure-
ment characteristics of various MOA, with generally
similar results. Namely, while various MOA may differ
in costs, completion rates, etc., the effects of MOA on
questionnaire measurement characteristics are generally
of “small to medium” size, if found at all. This would
suggest that one should exercise caution when mixing
MOA’s while investigating effects of similar magnitudes.
A limitation associated with the present investigation
concerns the post-randomization dropout of patients
prior to assessment. This occurred primarily in the in-
clinic condition. Almost 50% of the patients allocated to
this condition did not return to the clinic in time for
the present study. This differential drop-out (apparently)
lead to group differences in patient characteristics, such
as treatment, stage of disease, and pre-randomization
HRQoL measures. However, we believe that adjustment
for these patient characteristics in the statistical analyses
was largely able to correct for these group differences.
An additional, sensitivity analysis included these in-
clinic dropouts, who were approached via “pencil &
paper at home”. This analysis re-flagged the EF scale, as
well as the SL scale, indicating that the “telephone”
MOA yielded a more positive result than pencil & paper
conditions (which did not differ from each other). These
findings are commensurate with the finding reported
above.
A second limitation concerns the use of version 2.0 of
the EORTC QLQ-C30. There are, namely, slight differ-
ences with the current version 3.0, involving the number
of response categories for the Physical Function scales.
This might slightly limit the generalizability of these
results to users of version 3.0.
Conclusions
In conclusion, the findings of this investigation indicate
that the 3 modes of administration studied here have lit-
tle effect on the internal consistency or the mean
responses on the EORTC QLQ-C30 scales. The
Table 4 Adjusted# Means (+s.e.) for three MOA groups
EORTC QLQ-C30
All Scales
Paper & pencil at home
(N = 132)
Telephone
(N = 121)
Paper & Pencil in clinic
(N = 61)
Mean (s.e.) Mean (s.e.) Mean (s.e.) Sig.#
Physical function 68.9(2.9) 67.1(3.0) 65.3(3.6) .47
Role function 61.4(3.3) 62.2(3.3) 60.4(3.9) .86
Cognitive function 86.2(2.7) 86.0(2.8) 84.8(3.3) .87
Emotional function*
& 74.1(2.7) 79.5(2.8) 75.0(3.3) .04
Social function 79.1(3.1) 79.2(3.2) 76.9(3.8) .76
Global Health/QoL 64.7(2.6) 66.0(2.7) 64.5(3.2) .79
Fatigue 41.0(3.2) 41.9(3.2) 45.3(3.8) .42
Nausea/vomiting 6.9(2.9) 6.2(3.0) 7.5(3.5) .90
Pain 33.6(3.6) 33.1(3.7) 26.0(4.4) .11
Dyspnea 24.4(3.4) 26.4(3.5) 28.6(4.2) .48
Insomnia 30.5(4.3) 22.3(4.4) 27.3(5.2) .06
Anorexia 8.7(3.9) 13.4(4.0) 13.0(4.7) .29
Constipation 4.2(3.1) 4.8(3.1) 1.7(3.7) .61
Diarrhea 6.2(2.5) 6.4(2.6) 5.7(3.1) .97
Financial 10.4(2.9) 8.7(2.9) 5.8(3.5) .30
*p < 0.05 **p < 0.01
# adjusted for covariates in Tables 1 and 2
& overall effect size for Emotional Function scale are 0.16 for overall effect (Cohen’s f, based on partial eta squared) and 0.31, 0.14, 0.19 (Cohen’s d) for the
“telephone vs. paper & pencil at home”,t h e“paper & pencil at home vs. pencil & paper in-clinic”, and the “telephone vs. paper & pencil in-clinic” pairs of
conditions, respectively.
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tioning scale, which exhibited small, yet significant, dif-
ferences between various administration modes. These
results suggest that, with the possible exception of
assessment of emotional functioning, there is little rea-
son for concern about the comparison of QLQ-C30
results within or across studies as a function of mode of
administration.
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